Epivir (lamivudine) is associate antiviral drugs that forestalls human immunological disorder virus (HIV) or serum hepatitis virus cells from multiplying in your body.
Epivir is for treating HIV, that causes the noninheritable immunological disorder syndrome (AIDS). it’s not a cure for HIV or AIDS.
Epivir-HBV is for treating serum hepatitis. Epivir-HBV shouldn’t be employed in those that area unit infected witheach serum hepatitis and HIV.
Submit your review
Epivir, Epivir HBV
Get emergency medical help if you have signs of an allergic reaction to Epivir: hives; difficult breathing; swelling of your face, lips, tongue, or throat.
Some people develop lactic acidosis while taking Epivir. Early symptoms may get worse over time and this condition can be fatal. Get emergency medical help if you have even mild symptoms such as:
muscle pain or weakness;
numb or cold feeling in your arms and legs;
feeling dizzy, light-headed, tired, or very weak;
stomach pain, nausea with vomiting; or
fast or uneven heart rate.
Call your doctor at once if you have:
pancreas problems - severe pain in your upper stomach spreading to your back, nausea and vomiting, fast heart rate; or
liver problems - nausea, upper stomach pain, itching, tired feeling, loss of appetite, dark urine, clay-colored stools, jaundice (yellowing of the skin or eyes);
Common Epivir side effects may include:
cold symptoms such as stuffy nose, sneezing, sore throat; or
abnormal liver function tests.
The recommended dosage of EPIVIR in HIV‑1-infected adults is 300 mg daily, administered as either 150 mg taken orally twice daily or 300 mg taken orally once daily with or without food. If lamivudine is administered to a patient infected with HIV‑1 and HBV, the dosage indicated for HIV‑1 therapy should be used as part of an appropriate combination regimen